Fenretinide treatment accelerates atherosclerosis development in apoE‐deficient mice in spite of beneficial metabolic effects
Busnelli, Marco, Manzini, Stefano, Bonacina, Fabrizia, Soldati, Sabina, Barbieri, Silvia Stella, Amadio, Patrizia, Sandrini, Leonardo, Arnaboldi, Francesca, Donetti, Elena, Laaksonen, Rejio, PaltrinieLanguage:
english
Journal:
British Journal of Pharmacology
DOI:
10.1111/bph.14869
Date:
October, 2019
File:
PDF, 2.59 MB
english, 2019